These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 21245748

  • 1. Development of a new modified Bethesda method for coagulation inhibitors: the Osaka modified Bethesda method.
    Torita S, Suehisa E, Kawasaki T, Toku M, Takeo E, Tomiyama Y, Nishida S, Hidaka Y.
    Blood Coagul Fibrinolysis; 2011 Apr; 22(3):185-9. PubMed ID: 21245748
    [Abstract] [Full Text] [Related]

  • 2. A detailed comparison of the performance of the standard versus the Nijmegen modification of the Bethesda assay in detecting factor VIII:C inhibitors in the haemophilia A population of Canada. Association of Hemophilia Centre Directors of Canada. Factor VIII/IX Subcommittee of Scientific and Standardization Committee of International Society on Thrombosis and Haemostasis.
    Giles AR, Verbruggen B, Rivard GE, Teitel J, Walker I.
    Thromb Haemost; 1998 Apr; 79(4):872-5. PubMed ID: 9569207
    [Abstract] [Full Text] [Related]

  • 3. [Comparison of modified Bethesda assay and Nijmegen assay in detecting FVII inhibitor in patients with hemophilia A].
    Fan LK, Wang ZW, Hua BL, Su W, Wang SJ, Zhao YQ.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2009 Oct; 31(5):551-4. PubMed ID: 19968068
    [Abstract] [Full Text] [Related]

  • 4. The type of factor VIII deficient plasma used influences the performance of the Nijmegen modification of the Bethesda assay for factor VIII inhibitors.
    Verbruggen B, Giles A, Samis J, Verbeek K, Mensink E, Novákovà I.
    Thromb Haemost; 2001 Dec; 86(6):1435-9. PubMed ID: 11776311
    [Abstract] [Full Text] [Related]

  • 5. A standardized method for measuring anti-F VIII: C inhibitors in haemophilia A by coagulation inhibition in agarose gel.
    Jorquera JI, Carmona E, Aznar JA, Peiró A, Sánchez-Cuenca JM.
    Thromb Haemost; 1985 Aug 30; 54(2):377-80. PubMed ID: 3936211
    [Abstract] [Full Text] [Related]

  • 6. Improvements in factor VIII inhibitor detection: From Bethesda to Nijmegen.
    Verbruggen B, van Heerde WL, Laros-van Gorkom BA.
    Semin Thromb Hemost; 2009 Nov 30; 35(8):752-9. PubMed ID: 20169511
    [Abstract] [Full Text] [Related]

  • 7. Validation of 4% albumin as a diluent in the Bethesda Assay for FVIII inhibitors.
    Kershaw GW, Chen LS, Jayakodi D, Dunkley SM.
    Thromb Res; 2013 Nov 30; 132(6):735-41. PubMed ID: 24119613
    [Abstract] [Full Text] [Related]

  • 8. The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability.
    Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E.
    Thromb Haemost; 1995 Feb 30; 73(2):247-51. PubMed ID: 7792738
    [Abstract] [Full Text] [Related]

  • 9. Nijmegen-Bethesda assay to measure factor VIII inhibitors.
    Duncan E, Collecutt M, Street A.
    Methods Mol Biol; 2013 Feb 30; 992():321-33. PubMed ID: 23546724
    [Abstract] [Full Text] [Related]

  • 10. [Modified Bethesda, modified Nijmegen and blank assays for coagulation factor VIII inhibitor detection and factors affecting the results].
    Feng HM, Li Q, Xu WS, Chen DM, Zheng L.
    Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr 30; 36(4):592-5. PubMed ID: 27113194
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Does the presence of von Willebrand factor in FVIII-deficient plasma influences the measurement of FVIII inhibitor titres in haemophilia A patients?
    Pouplard C, Desconclois C, Sobas F, Aillaud MF, Ternisien C, Caron C.
    Int J Lab Hematol; 2015 Feb 30; 37(1):125-32. PubMed ID: 24815078
    [Abstract] [Full Text] [Related]

  • 15. [Detection of blood coagulation inhibitors using a modified Lossing-Kasper test].
    Meili EO, Büchter U, von Felten A.
    Schweiz Med Wochenschr; 1986 Oct 25; 116(43):1492-4. PubMed ID: 3097819
    [Abstract] [Full Text] [Related]

  • 16. Comparative measurement of FVIII inhibitors in hemophilia A patients using ELISA and the Bethesda assay.
    Kim SY, Kang SY, Lee WI.
    Korean J Lab Med; 2010 Jun 25; 30(3):260-3. PubMed ID: 20603586
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Laboratory identification of factor inhibitors: the perspective of a large tertiary hemophilia center.
    Kershaw G, Jayakodi D, Dunkley S.
    Semin Thromb Hemost; 2009 Nov 25; 35(8):760-8. PubMed ID: 20169512
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.